Arbutus Biopharma Corporation (ABUS) Stock Price History
Historical prices from 2011 to 2026
Loading 10-year price history...
ABUS Historical Performance
Short-Term Returns
ABUS Stock Price Trajectory (2011–2026)
As of May 8, 2026, Arbutus Biopharma Corporation (ABUS) trades at $4.35, representing a +32.2% return over the past year. The stock has delivered a +54.8% total return over five years (+9.1% CAGR), reflecting significant long-term value creation.
The stock reached its all-time high of $31.48 on March 13, 2014. From this peak, ABUS has corrected -86.2%, currently trading 2% above its 200-day moving average, indicating continued institutional support.
When compared to Healthcare sector peers REPL (-53.4% 1Y), ASMB (+149.2% 1Y), and HBIO (+126.3% 1Y), ABUS has underperformed the peer group average. Compare ABUS vs REPL →
ABUS Historical Price Data (2025–2026)
Showing 30 of 3,650 recordsLoading full history…
| Date | Open | High | Low | Close | Volume | Change % |
|---|---|---|---|---|---|---|
| 2026-05-07 | 4.41 | 4.45 | 4.28 | 4.35 | 920K | -1.58% |
| 2026-05-06 | 4.45 | 4.48 | 4.39 | 4.42 | 1.01M | +0.50% |
| 2026-05-05 | 4.44 | 4.54 | 4.35 | 4.40 | 263K | +0.18% |
| 2026-05-04 | 4.29 | 4.47 | 4.26 | 4.39 | 787K | +1.62% |
| 2026-05-01 | 4.17 | 4.33 | 4.17 | 4.32 | 776K | +2.86% |
| 2026-04-30 | 4.20 | 4.23 | 4.13 | 4.20 | 761K | +1.69% |
| 2026-04-29 | 4.10 | 4.14 | 4.01 | 4.13 | 1.10M | -0.48% |
| 2026-04-28 | 4.27 | 4.34 | 4.09 | 4.15 | 1.26M | -3.04% |
| 2026-04-27 | 4.17 | 4.33 | 4.17 | 4.28 | 5.04M | +1.90% |
| 2026-04-24 | 4.29 | 4.29 | 4.05 | 4.20 | 7.96M | -1.18% |
| 2026-04-23 | 4.40 | 4.43 | 4.15 | 4.25 | 4.99M | -4.06% |
| 2026-04-22 | 4.46 | 4.48 | 4.41 | 4.43 | 927K | 0.00% |
| 2026-04-21 | 4.60 | 4.63 | 4.42 | 4.43 | 891K | -3.70% |
| 2026-04-20 | 4.70 | 4.71 | 4.59 | 4.60 | 858K | -2.54% |
| 2026-04-17 | 4.68 | 4.75 | 4.60 | 4.72 | 1.03M | +0.85% |
| 2026-04-16 | 4.50 | 4.75 | 4.48 | 4.68 | 2.21M | +4.46% |
| 2026-04-15 | 4.56 | 4.75 | 4.43 | 4.48 | 3.27M | +2.99% |
| 2026-04-14 | 4.39 | 4.45 | 4.32 | 4.35 | 1.34M | -0.46% |
| 2026-04-13 | 4.14 | 4.38 | 4.14 | 4.37 | 1.32M | +5.30% |
| 2026-04-10 | 4.31 | 4.33 | 4.13 | 4.15 | 2.62M | -3.49% |
| 2026-04-09 | 4.38 | 4.42 | 4.25 | 4.30 | 1.83M | -1.83% |
| 2026-04-08 | 4.59 | 4.60 | 4.36 | 4.38 | 1.94M | -1.79% |
| 2026-04-07 | 4.41 | 4.47 | 4.35 | 4.46 | 824K | 0.00% |
| 2026-04-06 | 4.49 | 4.60 | 4.46 | 4.46 | 688K | -0.45% |
| 2026-04-02 | 4.43 | 4.54 | 4.37 | 4.48 | 594K | -0.88% |
| 2026-04-01 | 4.54 | 4.62 | 4.47 | 4.52 | 1.19M | +0.44% |
| 2026-03-31 | 4.37 | 4.57 | 4.37 | 4.50 | 2.04M | +4.65% |
| 2026-03-30 | 4.26 | 4.35 | 4.21 | 4.30 | 1.05M | +0.23% |
| 2026-03-27 | 4.51 | 4.55 | 4.28 | 4.29 | 1.35M | -3.60% |
| 2026-03-26 | 4.46 | 4.58 | 4.42 | 4.45 | 1.70M | -1.77% |
See ABUS's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs ABUS Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare ABUS vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonABUS — Frequently Asked Questions
Quick answers to the most common questions about buying ABUS stock.
How has ABUS stock performed recently?
ABUS returned +32.2% over the past year, beating its 5-year annualized CAGR of +9.1%. The stock trades above its 200-day moving average, confirming the uptrend.
What is ABUS's all-time high price?
Arbutus Biopharma Corporation reached $31.48 on 2014-03-13. The 52-week high is $5.10. Current 1-year return of +32.2% places the stock closer to historical peaks.
Where can I download ABUS historical price data?
This page provides ABUS daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2011-2026, downloadable in CSV format.